 Novavax Inc. NVAX, -10.14 said Tuesday that one million doses of its protein-based COVID vaccine Nuvaxovid are now available in the U.K. With U.K. data showing that people infected with both COVID-19 and the flu are more than five times as likely to die compared to someone with no infection1 , it is more important than ever to consider any vaccine offered to you by the National Health Service, said Stanley C. Erck, Novavax chief executive, in a statement. 